A detailed history of Thrivent Financial For Lutherans transactions in Biolife Solutions Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 28,261 shares of BLFS stock, worth $735,068. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,261
Previous 30,188 6.38%
Holding current value
$735,068
Previous $647,000 9.43%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$19.19 - $26.52 $36,979 - $51,104
-1,927 Reduced 6.38%
28,261 $708,000
Q2 2024

Aug 13, 2024

SELL
$15.14 - $22.99 $10,370 - $15,748
-685 Reduced 2.22%
30,188 $647,000
Q1 2024

May 14, 2024

SELL
$15.35 - $18.82 $1,888 - $2,314
-123 Reduced 0.4%
30,873 $573,000
Q4 2023

Feb 14, 2024

SELL
$8.99 - $16.86 $3,901 - $7,317
-434 Reduced 1.38%
30,996 $504,000
Q3 2023

Nov 14, 2023

SELL
$10.81 - $22.96 $3.41 Million - $7.24 Million
-315,402 Reduced 90.94%
31,430 $434,000
Q2 2023

Aug 14, 2023

SELL
$17.19 - $24.34 $55,265 - $78,253
-3,215 Reduced 0.92%
346,832 $7.67 Million
Q1 2023

May 17, 2023

BUY
$17.67 - $26.07 $127,842 - $188,616
7,235 Added 2.11%
350,047 $7.61 Million
Q4 2022

Feb 08, 2023

BUY
$16.95 - $25.07 $72,427 - $107,124
4,273 Added 1.26%
342,812 $6.24 Million
Q3 2022

Nov 14, 2022

BUY
$14.64 - $26.7 $868,854 - $1.58 Million
59,348 Added 21.26%
338,539 $7.7 Million
Q2 2022

Aug 16, 2022

BUY
$10.54 - $24.2 $705,758 - $1.62 Million
66,960 Added 31.55%
279,191 $3.86 Million
Q1 2022

May 13, 2022

BUY
$20.81 - $37.29 $3.92 Million - $7.02 Million
188,383 Added 789.93%
212,231 $4.82 Million
Q4 2021

Feb 16, 2022

BUY
$32.99 - $58.55 $11,282 - $20,024
342 Added 1.45%
23,848 $889,000
Q3 2021

Nov 15, 2021

BUY
$42.03 - $60.5 $987,957 - $1.42 Million
23,506 New
23,506 $995,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.11B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.